Vincent Milano insider trades: Biocryst Pharmaceuticals (BCRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vincent reports to the SEC
and 2 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 20, 2024 | BCRX | ↑ Buy | 15,000 | $6.25 | $94K | Direct | May 22, 2024 (2d) |
| Aug 10, 2023 | ACGN | ↓ Sell | 3,283 | $0.53 | $2K | Direct | Aug 11, 2023 (1d) |
| Nov 24, 2021 | BCRX | ↑ Buy | 7,500 | $12.19 | $91K | Direct | Nov 24, 2021 (0d) |
| Jan 12, 2021 | IDRA | ↓ Sell | 3,210 | $4.20 | $13K | Direct | Jan 12, 2021 (0d) |
| Jan 5, 2021 | IDRA | ↓ Sell | 2,740 | $3.91 | $11K | Direct | Jan 11, 2021 (6d) |
| Dec 22, 2020 | IDRA | ↓ Sell10b5-1 | 37,169 | $4.32 | $161K | Direct | Dec 22, 2020 (0d) |
| Jan 7, 2020 | IDRA | ↓ Sell | 3,006 | $1.78 | $5K | Direct | Jan 10, 2020 (3d) |
| Dec 24, 2018 | IDRA | ↑ Buy | 15,000 | $2.93 | $44K | Direct | Dec 26, 2018 (2d) |
| Aug 7, 2018 | IDRA | ↑ Buy | 10,000 | $5.51 | $55K | Direct | Aug 8, 2018 (1d) |
| Mar 15, 2016 | IDRA | ↑ Buy | 40,000 | $1.97 | $79K | Direct | Mar 17, 2016 (2d) |
| Dec 12, 2014 | IDRA | ↑ Buy | 200,000 | $4.00 | $799K | Direct | Dec 15, 2014 (3d) |
| Nov 8, 2012 | VPHM | ↓ Sell | 83,418 | $24.54 | $2.0M | Direct | Nov 13, 2012 (5d) |
| Nov 21, 2011 | VPHM | ↓ Sell | 76,687 | $22.53 | $1.7M | Direct | Nov 23, 2011 (2d) |
| Feb 27, 2009 | VPHM | ↑ Buy | 2,300 | $4.16 | $10K | Direct | Feb 27, 2009 (0d) |
| Aug 16, 2007 | VPHM | ↑ Buy | 4,000 | $8.16 | $33K | Direct | Aug 17, 2007 (1d) |
| Dec 13, 2005 | VPHM | ↓ Sell | 59,999 | $19.82 | $1.2M | Direct | Dec 15, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BCRX insiders
Open-market trades in the last 12 months
About Vincent Milano's insider trades
Vincent Milano is a director at Biocryst Pharmaceuticals (BCRX). Since Dec 13, 2005, Vincent has reported 8 open-market purchases worth $1.2M and 8 sales worth $5.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (78 filings), option exercises (19 filings), shares withheld for taxes (4 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.